In the last trading session, 2.76 million shares of the Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) were traded, and its beta was -0.08. Most recently the company’s share price was $1.81, and it changed around $0.01 or 0.56% from the last close, which brings the market valuation of the company to $81.59M. RVPH currently trades at a discount to its 52-week high of $5.67, offering almost -213.26% off that amount. The share price’s 52-week low was $0.60, which indicates that the current value has risen by an impressive 66.85% since then. We note from Reviva Pharmaceuticals Holdings Inc’s average daily trading volume that its 10-day average is 6.04 million shares, with the 3-month average coming to 2.03 million.
Reviva Pharmaceuticals Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended RVPH as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
Instantly RVPH has showed a green trend with a performance of 0.56% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.9200 on recent trading dayincreased the stock’s daily price by 5.73%. The company’s shares are currently down -64.85% year-to-date, but still up 35.07% over the last five days. On the other hand, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) is 58.77% up in the 30-day period. We can see from the shorts that 5.3 million shares have been sold at a short interest cover period of 19.04 day(s).
Reviva Pharmaceuticals Holdings Inc (RVPH) estimates and forecasts
Reviva Pharmaceuticals Holdings Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 52.10 percent over the past six months and at a 38.79% annual growth rate that is well above the industry average of 16.60%.
RVPH Dividends
Reviva Pharmaceuticals Holdings Inc’s next quarterly earnings report is expected to be released in January.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 14.79% of Reviva Pharmaceuticals Holdings Inc shares, and 30.07% of them are in the hands of institutional investors. The stock currently has a share float of 35.28%. Reviva Pharmaceuticals Holdings Inc stock is held by 35.0 institutions, with WOODLINE PARTNERS LP being the largest institutional investor. By 2024-06-30, it held 6.6273% of the shares, which is about 1.59 million shares worth $2.04 million.
MILLENNIUM MANAGEMENT LLC, with 5.1656% or 1.24 million shares worth $1.59 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
